# A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity

> **NCT04915729** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1489 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** tenecteplase
- **DRUG:** alteplase

## Key facts

- **NCT ID:** NCT04915729
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-22
- **Primary completion:** 2023-10-08
- **Final completion:** 2023-10-08
- **Target enrollment:** 1489 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04915729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04915729, "A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04915729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*